Effect of verapamil on pharmacokinetics of puerarin in rats

Zhongguo Zhongyao Zazhi

Volumn 33, Issue 16, 2008, Pages 2033-2036

  Cui, Sheng Miao ^a   Ma, Yan Bin ^b  

^a GUANGDONG PHARMACEUTICAL UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

Pharmacokinetics; Puerarin; Verapamil

Indexed keywords

ISOFLAVONE DERIVATIVE; PUERARIN; VASODILATOR AGENT; VERAPAMIL;

ANIMAL; ARTICLE; BLOOD; DRUG INTERACTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; ORAL DRUG ADMINISTRATION; RAT;

ADMINISTRATION, ORAL; ANIMALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG INTERACTIONS; ISOFLAVONES; MALE; RATS; VASODILATOR AGENTS; VERAPAMIL;

EID: 52649169329     PISSN: 10015302     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Chinese source
2. Guerre M C, Speroni E, Broccoli M, et al. Comparison between chinese medical herb pueraria lobata crude extract and its main isoflavone puerarin antioxidant properties and effects on rat liver CYP2 catalysed drug metabolis[J]. Life Sci,2000,67:2997.
3. Hines R N. Ontogeny of human hepatic cytochromes P450[J]. J Biochem Mol Toxicol,2007,21(4):169.
4. Bertilsson L. Metabolism of antidepressant and neuroleptic drugs by cytochrome P450s: clinical and interethnic aspects[J]. Clin Pharmacol Ther,2007,82(5):606.
5. Zhou S, Yung C S, Cher GB, et al. Mechanism-based inhibition of cytochrome P4503A4 by therapeutic drugs[J]. Clin Pharmacokinet,2005,44(3):279.